Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #351 to #400.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Retrievability‏‎ (2 revisions)
  2. Immune system‏‎ (2 revisions)
  3. Institutional control‏‎ (2 revisions)
  4. Cumulative dose‏‎ (2 revisions)
  5. Stakeholder‏‎ (2 revisions)
  6. Tachycardia‏‎ (2 revisions)
  7. Tissue equivalent material‏‎ (2 revisions)
  8. Dose conversion coefficient‏‎ (2 revisions)
  9. Myocardial stress test‏‎ (2 revisions)
  10. Effect Dose 50‏‎ (2 revisions)
  11. Worker‏‎ (2 revisions)
  12. Nuclear track detectors‏‎ (2 revisions)
  13. Endogeneous excretion‏‎ (2 revisions)
  14. Exposure to Radon at Home‏‎ (2 revisions)
  15. GATA binding protein 2‏‎ (2 revisions)
  16. Radiation safety officer‏‎ (2 revisions)
  17. Radioresponsiveness‏‎ (2 revisions)
  18. Hormones‏‎ (2 revisions)
  19. Authorization‏‎ (2 revisions)
  20. Recovery responder‏‎ (2 revisions)
  21. Reversibility‏‎ (2 revisions)
  22. Clonogenic cells‏‎ (2 revisions)
  23. In vivo radiobioassay‏‎ (2 revisions)
  24. Solar particle event‏‎ (2 revisions)
  25. Curie‏‎ (2 revisions)
  26. Working level‏‎ (2 revisions)
  27. OLINDA/EXM‏‎ (2 revisions)
  28. Particle radiance‏‎ (2 revisions)
  29. Protection strategy‏‎ (2 revisions)
  30. Acute radiation syndrome‏‎ (2 revisions)
  31. Radiation source‏‎ (2 revisions)
  32. Radiosensitiser‏‎ (2 revisions)
  33. Hounsfield unit‏‎ (2 revisions)
  34. Authorized limit‏‎ (2 revisions)
  35. Rehabilitation of living conditions‏‎ (2 revisions)
  36. Cardiac arrhythmias‏‎ (2 revisions)
  37. Right to know‏‎ (2 revisions)
  38. Clonogenic survival‏‎ (2 revisions)
  39. Incidence‏‎ (2 revisions)
  40. Solar wind‏‎ (2 revisions)
  41. Cytokines‏‎ (2 revisions)
  42. Target tissue‏‎ (2 revisions)
  43. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  44. Working level month‏‎ (2 revisions)
  45. Environmental exposure‏‎ (2 revisions)
  46. Exempt waste‏‎ (2 revisions)
  47. Adaptive response‏‎ (2 revisions)
  48. Alveolar-interstitial region‏‎ (2 revisions)
  49. Radiosensitivity, cellular‏‎ (2 revisions)
  50. Autoimmune disease‏‎ (2 revisions)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)